HS
RVMD icon

HighVista Strategies’s Revolution Medicines RVMD Stock Holding History

HighVista Strategies’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
66,983
-2,326
-3% -$340K 2.86% 3
2026
Q1 		$6.74M Sell
69,309
-50,931
-42% -$5.14M 1.86% 7
2025
Q4 		$9.58M Sell
120,240
-55,208
-31% -$3.62M 2.47% 6
2025
Q3 		$8.19M Buy
175,448
+107,400
+158% +$4.21M 2.01% 5
2025
Q2 		$2.5M Sell
68,048
-5,704
-8% -$219K 0.92% 27
2025
Q1 		$2.61M Buy
73,752
+16,506
+29% +$670K 1% 18
2024
Q4 		$2.5M Buy
57,246
+1,684
+3% +$85K 0.93% 28
2024
Q3 		$2.52M Buy
55,562
+15,479
+39% +$674K 0.87% 34
2024
Q2 		$1.56M Buy
40,083
+25,758
+180% +$963K 0.57% 64
2024
Q1 		$462K Sell
14,325
-8,325
-37% -$247K 0.16% 122
2023
Q4 		$650K Buy
22,650
+4,645
+26% +$112K 0.24% 108
2023
Q3 		$498K Buy
+18,005
New +$534K 0.23% 108
2022
Q4 		– Sell
-42,056
Closed -$829K – 124
2022
Q3 		$829K Buy
42,056
+21,371
+103% +$470K 0.47% 52
2022
Q2 		$403K Buy
+20,685
New +$403K 0.24% 81
2021
Q4 		– Sell
-23,637
Closed -$650K – 108
2021
Q3 		$650K Sell
23,637
-1,401
-6% -$40.8K 0.43% 66
2021
Q2 		$795K Buy
25,038
+8,046
+47% +$281K 0.56% 52
2021
Q1 		$780K Buy
+16,992
New +$762K 0.58% 30

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

HighVista Strategies's RVMD Position: Q2 2026 in Review

HighVista Strategies reduced its Revolution Medicines (RVMD) stake by 3.4% in Q2 2026, selling an estimated $340K and leaving 66,983 shares worth $12.5M. The position accounts for 2.86% of the portfolio, ranked #3.

HighVista Strategies first reported a position in RVMD in Q1 2021 and has held it in 17 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • HighVista Strategies held 66,983 shares of Revolution Medicines worth $12.5M as of Q2 2026.
  • HighVista Strategies sold 2,326 Revolution Medicines shares in Q2 2026, an estimated $340K.
  • Revolution Medicines made up 2.86% of HighVista Strategies's portfolio in Q2 2026, its #3 holding.
  • HighVista Strategies first reported a position in Revolution Medicines in Q1 2021 and has held it in 17 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HighVista Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.